Magnitude of weight loss, cardiovascular profile, eligibility (including the adolescent indication for Wegovy), tolerability, medication cost, and goals all feed into the recommendation
The overall result is steadier blood sugar, less insulin demand, and improved insulin sensitivity over time
Louie T, Golan Y, Khanna S, Bobilev D, Erpelding N, Fratazzi C, et al
A 68-week randomised controlled trial of semaglutide in adults with overweight or obesity (without diabetes) found that while approximately 39% of the total weight lost was lean mass, this was within an acceptable clinical range and mostly proportional to the degree of total weight loss [4]
If symptoms escalate, pause titration and contact your clinician for tailored adjustment
Trong cc t bo v m khe mnh, hn 90% tng s Glutathion tn ti dng kh (GSH) v di 10% tn ti dng disulfide (GSSG)